NEW YORK (GenomeWeb) – Genomic services provider Macrogen said on Tuesday that it has signed a one-year agreement to be the exclusive buyer of Exosome Plus' Exo2D exosome isolation kits.

The South Korean companies have also signed a memorandum of understanding to collaborate on the development of exosome-based biomedical products including diagnostics and therapeutics.